Stock Market Update

02-Sep-25 12:00 ET
Health care sector displays resilience
Dow -529.79 at 45015.09, Nasdaq -406.80 at 21048.75, S&P -95.68 at 6364.58

[BRIEFING.COM] The S&P 500 (-1.5%), Nasdaq Composite (-1.9%), and DJIA (-1.2%) are plotting new session lows as losses widen across the majority of sectors.

As it stands, the consumer staples (+0.1%), energy (-0.1%), health care (-0.4%), and utilities (-0.4%) sectors are the only S&P 500 sectors without a loss wider than 0.5%. 

The health care sector benefits from a relatively strong performance in its biotech names that have the iShares Biotechnology ETF up 0.8%. 

Biogen (BIIB 136.97, +4.75, +3.59%) is one of the best-performing names in the S&P 500, following the announcement that the company and Eisai received FDA approval for LEQEMBI IQLIKTM (lecanemab-irmb), a subcutaneous injection for maintenance dosing for the treatment of early Alzheimer's disease.

Vertex Pharma (VRTX 397.30, +6.28, +1.61%) and Alnylam Pharma (ALNY 448.91, +2.40, +0.54%) are among the other top holdings with positive standings today.

Elsewhere in the sector, managed health care names such as Centene (CNC 29.59, +0.55, +1.90%) and Elevance Health (ELV 324.36, +5.70, +1.79%) help to prevent further losses. 

Cookies are essential for making our site work. By using our site, you consent to the use of these cookies. Read our cookie policy to learn more.